| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.171.940.662 $ | +201.798.707 $ | +13,0 % | 8 | 1.021.216.802 $ | +409.224.575 $ | +93,7 % | 9 | 638.903.910 $ | +138.211.390 $ | +32,7 % | 8 | ||||
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 445.715.088 $ | +215.736.822 $ | +93,8 % | 1 | 229.978.266 $ | +84.576.325 $ | +58,2 % | 1 | 145.401.941 $ | +6.235.380 $ | +4,5 % | 1 |
| Krystal Biotech, Inc. | KRYS | → 0 | Neutral | 173.979.812 $ | +6.898.421 $ | +4,1 % | 1 | 167.081.391 $ | +50.326.567 $ | +43,1 % | 1 | 116.754.824 $ | +25.554.100 $ | +28,0 % | 1 |
| Nurix Therapeutics, Inc. | NRIX | → 0 | Neutral | 119.858.524 $ | -33.682.911 $ | -21,9 % | 1 | 153.541.435 $ | +119.553.074 $ | +351,7 % | 1 | ||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 135.583.747 $ | +7.542.365 $ | +5,9 % | 1 | 128.041.382 $ | +29.916.145 $ | +30,5 % | 1 | 98.125.237 $ | +48.458.420 $ | +97,6 % | 1 |
| Immunome Inc. | IMNM | → 0 | Neutral | 121.572.815 $ | -1.258.095 $ | -1,0 % | 1 | 122.830.910 $ | +64.007.072 $ | +108,8 % | 1 | 58.823.838 $ | +13.512.145 $ | +29,8 % | 1 |
| Annexon, Inc. | ANNX | → 0 | Schwach | 80.605.715 $ | +30.151.482 $ | +59,8 % | 1 | 50.454.233 $ | +31.237.269 $ | +162,6 % | 1 | ||||
| Zymeworks Inc. | ZYME | → 0 | Neutral | 63.294.210 $ | +11.203.841 $ | +21,5 % | 1 | ||||||||
| REGENXBIO Inc. | RGNX | → 0 | Schwach | 36.610.578 $ | -26.300.200 $ | -41,8 % | 1 | 62.910.778 $ | +17.619.574 $ | +38,9 % | 1 | 45.291.204 $ | +6.082.567 $ | +15,5 % | 1 |
| ADC Therapeutics SA | ADCT | → 0 | Neutral | 58.014.383 $ | +2.710.823 $ | +4,9 % | 1 | 55.303.560 $ | -7.363.364 $ | -11,8 % | 1 | 62.666.924 $ | +20.680.085 $ | +49,3 % | 1 |
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 51.074.847 $ | +19.351.913 $ | +61,0 % | 1 | ||||||||
| LivaNova PLC | LIVN | → 0 | Neutral | 48.545.732 $ | +6.484.852 $ | +15,4 % | 1 | ||||||||
| 1.171.940.662 $ | +201.798.707 $ | +13,0 % | 8 | 1.021.216.802 $ | +409.224.575 $ | +93,7 % | 9 | 638.903.910 $ | +138.211.390 $ | +32,7 % | 8 | ||||